Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naomai No.2 capsule
- Development stage
- Unknown
- Lead developer
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Naomai No.2 capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine for the treatment of severe intracerebral hemorrhage (ICH). As a hospital-developed preparation, it is typically used as an adjunctive therapy alongside conventional medical management. The capsule's therapeutic effects are hypothesized to stem from its ability to improve cerebral blood flow, protect the integrity of the blood-brain barrier, and modulate vascular endothelial function. Additionally, it is studied for its potential to reduce neuroinflammation and improve neurological recovery, with clinical trials utilizing multimodal brain function monitoring, including EEG and cerebral blood flow assessments, to evaluate its efficacy in patients with severe supratentorial ICH.
- Brand names
- Naomai No.2 capsule
- Other names
- Naomai No. 2 capsuleNaomai II capsule
Beyond the preview
Go deeper on Naomai No.2 capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Naomai No.2 capsule.